Medtronic secures $337m from Blackstone to develop diabetes technologies
Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new, innovative products particularly designed to ease the ... Read More
Cell therapy company Talaris Therapeutics raises $100m in Series A round
Talaris Therapeutics (formerly Regenerex) has raised $100 million in a Series A financing round to advance its allogeneic cell therapy FCR001 into phase 3 development ... Read More